Psychedelic Retreats: Risks & Rewards

0:00It's April 20th. From your city to your ears, this is Canada News Today, powered by AI. Psychedelic retreats are popping up everywhere, with hundreds worldwide offering multi-day trips where folks pay for mind-altering drug experiences, promising healing and growth. These spots use stuff like magic mushrooms, ayahuasca, MDMA, and LSD, but they're straight up illegal under U.S. federal law, even if some claim. Religious exemptions. President Trump just signed an executive order pushing the FDA to speed up reviews for psychedelics treating things like PTSD, and it tells law. Enforcement to ease restrictions once approved. Meanwhile, retreats often happen in places like Peru or Brazil where these substances face fewer bands. Experts like Yale psychiatrist John Crystal warned these should be handled like serious medical procedures with real risks, but the scenes grown safer. Then underground days of the past. More demand means better staffing, medical pros on site, and safety protocols, according to folks in the field.

1:04A new study in JAMA Network Open surveyed dozens of retreats and found big gaps, no industry standards for screening, prep, or follow-up. Over half-screened out severe mental illnesses, but they rely on self-reported health history and nearly 90% push-stopping anti-depressants. For weeks, which docs say needs supervised tapering to avoid dangers. As this market booms, potential goers got a vet hard, check emergency plans, nearby hospitals, and real integration support, maybe via review sites, while weighing the hype against those unmanaged risks.